Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2026-04-24 @ 1:48 AM
Study NCT ID:
NCT06013618
Status:
RECRUITING
Last Update Posted:
2025-06-17
First Post:
2023-08-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-19
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-19
First Submit QC Date:
None
Study First Post Date:
2023-08-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-13
Last Update Post Date:
2025-06-17
Last Update Post Date Type:
ACTUAL